Nanobios Lab

Dr. Rohit Srivastava is currently working as a Professor at the Indian Institute of Technology, Bombay. Dr. Srivastava completed his Bachelor of Engineering in Electronics Engineering from VNIT Nagpur in 1999 with distinction and was the recipient of scholarship of merit for graduating students for the year. He joined Tata Consultancy Services, SEEPZ, Mumbai for a short duration of a year. Not finding satisfaction in what he was doing, he decided to complete higher studies in the US. He subsequently went on to finish a Master of Science and a PhD in Biomedical Engineering from Louisiana Tech University, Ruston, LA, USA for which he received the best student of the year award in 2005. His specialization lies in POC Diagnostic devices, Biomedical Microsystems devices (MEMS), nanoengineered biosensors, photothermal therapy in cancers and nanoengineered orthopedic applications. His lab has graduated 21 PhD students and 50 Master’s students at IIT Bombay. Currently, his lab at IIT Bombay comprises of 15 PhD students, 3 Master’s students, 3 post-docs, 10 interns and 9 staff. His lab has funded projects across all domains, from point of care diagnostic devices to biosensors to cancer nanotechnology to MEMS drug delivery devices.

Dr Srivastava’s lab in collaboration with Biosense Technologies Pvt Ltd have already developed and commercialized “UChek” a portable urine analysis system based on the mobile platform and have also made a low cost reader for quantitatively analyzing urine dip sticks for which he has received the DBT Biotech Process and Product Commercialization Award 2015 and the OPPI Young Investigator Award 2014. He has been awarded the prestigious Vasvik Award 2013 for Biological Sciences and Technology for Suchek, which is an indigenous, accurate, low-cost
glucometer supported by the Indian Council of Medical Research. Dr Srivastava is also the recipient of the prestigious Tata Innovation Fellowship Award from DBT for his translational work on diagnosing orthopedic implant related infections. He has recently been awarded the prestigious DBT National Bioscience Award for his efforts in translating technologies from lab. He has recently been awarded the prestigious NASI Reliance Industries Platinum Jubilee Awards 2018 for Application Oriented Innovations in Physical Sciences.
 

Dr Srivastava is the proud recipient of the Bill and Melinda Gates Foundation GCE Phase 1 for an innovative work on drug delivery using microneedles. Dr Srivastava’s lab has been placed third in the prestigious Healthcare Innovation World Cup organized by HIT Lab on solutions to management of diabetes with a cash award of $5000. The Wellcome Trust UK has further funded this project for making an affordable point of care reader for critical care analytes. Dr Srivastava’s lab is also the winner of prestigious ‘Samsung Innovation Award 2012’ organized by IIT Delhi  (August 2012) for innovation ‘Drishti which has been transferred to Titan Eye for further development. Dr Srivastava has been conferred the Sr IYBA award in May 2013. He has received the INAE Young Associateship in 2013. He has received the prestigious INAE Young Engineer Award 2010. He is also the recipient of the prestigious DBT-IYBA 2009 award. He has also been elected a Member of the National Academy of Sciences, 2011. Further, he has been awarded the Young Investigator awards from IIT Bombay (2010), DAE (2006) and DST (2006) and is also the recipient of technical awards from Intellectual Ventures Asia Pte Ltd. 80 of his 2 current ideas have been submitted as patent and design applications to the US and Indian Patent Office with several of them approved, published and under review. In a short duration of 13 years at IIT Bombay, Dr. Srivastava has already published in more than 130 international journals and 100 international conference proceedings with an h-index of 25. He has been instrumental in encouraging 6 of his students to setup Companies either through a TBI or otherwise. He is on the panel of several companies where he mentors them through startup grants. Dr. Srivastava’s lab is focusing on developing technologies that can be commercialized and brought to use for the common man in India.